Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Bibliographic Details
Main Authors:	Matsunaga, Shinji, Kishi, Taro, Iwata, Nakao
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393306/

Similar Items

Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by: Matsunaga, Shinji, et al.
Published: (2015)

Memantine for the treatment of frontotemporal dementia: a meta-analysis
by: Kishi, Taro, et al.
Published: (2015)

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
by: Kishi, Taro, et al.
Published: (2015)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
by: Kishi, Taro, et al.
Published: (2015)

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Okuyama, Yuji, et al.
Published: (2016)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
by: Kishi, Taro, et al.
Published: (2014)

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials
by: Kishi, Taro, et al.
Published: (2015)

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
by: Matsunaga, Shinji, et al.
Published: (2015)

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Systematic Review and Meta-Analysis
by: Lockhart, I.A., et al.
Published: (2011)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Oya, Kazuto, et al.
Published: (2015)

Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Kishi, Taro, et al.
Published: (2014)

Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials
by: Kishi, Taro, et al.
Published: (2016)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
by: Farrimond, Lucy E, et al.
Published: (2012)

Meta-analysis of six-month memantine trials in Alzheimers disease
Published: (2008)

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias
by: Muayqil, Taim, et al.
Published: (2012)

Memantine-induced Myoclonus in a Patient with Alzheimer Disease
by: Murgai, Aditya A., et al.
Published: (2015)

Important Error in ‘Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias’ by Muayqil and Camicioli
by: Tariot, Pierre N., et al.
Published: (2014)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer’s disease in the Netherlands
by: Hoogveldt, Bart, et al.
Published: (2011)

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi, Taro, et al.
Published: (2016)

Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
by: Atri, Alireza, et al.
Published: (2015)

Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
by: Wang, Xiaochuan, et al.
Published: (2015)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
by: Parsons, Chris G., et al.
Published: (2013)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
by: Elena Sánchez-López, et al.
Published: (2018-03-01)

Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
by: Rive, Benoît, et al.
Published: (2013)

Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
by: Lídia Blanco-Silvente, et al.
Published: (2018-07-01)

Pesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis
by: Yan, Dandan, et al.
Published: (2016)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials
by: Molino, Ivana, et al.
Published: (2013)

Systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17
by: Kasuga, Kensaku, et al.
Published: (2015)

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer’s disease to nursing homes: cost-effectiveness analysis in France
by: Touchon, Jacques, et al.
Published: (2013)

Efficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-Analysis
by: Li, Rui, et al.
Published: (2015)

Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review
by: Weijenberg, Amerins, et al.
Published: (2015)

Pharmacokinetics of memantine in rats and mice
by: Beconi, Maria G., et al.
Published: (2012)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
by: Zhao, Yueren, et al.
Published: (2013)

Early prediction of blonanserin response in Japanese patients with schizophrenia
by: Kishi, Taro, et al.
Published: (2014)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
by: Jones, Rob, et al.
Published: (2009)

False recognition in a mouse model of Alzheimer’s disease: rescue with sensory restriction and memantine
by: Romberg, Carola, et al.
Published: (2012)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
by: Deardorff, William James, et al.
Published: (2016)

In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
by: Reggiani, Angelo M., et al.
Published: (2016)

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
by: Ismaila, Afisi Segun, et al.
Published: (2015)

The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
by: Kawalec, Paweł, et al.
Published: (2014)